Towards the Development of Multiplexed Cellular Therapies: The Promise of iPSC Derived T-cell Products

Time: 4:00 pm
day: Day 1 - Track A - Post Lunch


  • Design of effective allogeneic cell therapies requires multiplexed engineering.
  • Clinical success in solid tumor settings will require multiple mechanisms of action.
  • Stem Cell derived products enable identification and expansion of engineered products without deleterious off target damage.
  • Control of Notch signaling is critical for lineage commitment and differentiation potential of developing T-cells